• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一株对α-二氟甲基鸟氨酸具有抗性的布氏锥虫突变体。

A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.

作者信息

Phillips M A, Wang C C

出版信息

Mol Biochem Parasitol. 1987 Jan 2;22(1):9-17. doi: 10.1016/0166-6851(87)90064-8.

DOI:10.1016/0166-6851(87)90064-8
PMID:3100950
Abstract

Procyclic Trypanosoma brucei brucei strain 366D is susceptible to DL-alpha-difluoromethylornithine (DFMO) with an in vitro ED50 value of 225 microM. A mutant of the procyclic strain resistant to 20 mM of DFMO was isolated by serial in vitro passages of the organisms in increasing concentrations of the drug. Drug resistance remains unchanged after at least ten serial passages in the absence of DFMO. The mutant contains the same level of ornithine decarboxylase activity as the wild-type procyclic, and the mutant enzyme exhibits a similar susceptibility toward DFMO as the wild type. Neither the rate of decarboxylation of ornithine, nor the membrane potential in the mutant cell is changed. The only observed change in the mutant is its significantly decreased uptake of DFMO which reaches a saturating level of 18 microM inside the cells; a concentration seven times below the Ki value of DFMO on T. brucei ornithine decarboxylase (130 microM). Apparently, the failure of DFMO uptake in the mutant strain has provided the basis of drug resistance. The results also raise the question on whether the uptake of DFMO by T. brucei is by passive diffusion or by transporter(s) mediation. DFMO does not compete with the uptake of ornithine, arginine or putrescine, and the reverse holds also true. However, the mutant strain cultivated under DFMO for several generations has a greatly enhanced uptake of ornithine and a moderately heightened uptake of putrescine. Both are reduced to the normal level upon further propagations of the mutant strain in the absence of DFMO.

摘要

原循环型布氏布氏锥虫366D株对DL-α-二氟甲基鸟氨酸(DFMO)敏感,体外半数有效浓度(ED50)值为225微摩尔。通过在不断增加药物浓度的情况下对该生物体进行连续体外传代,分离出了对20毫摩尔DFMO具有抗性的原循环型菌株突变体。在无DFMO的情况下至少连续传代十次后,耐药性保持不变。该突变体所含鸟氨酸脱羧酶活性水平与野生型原循环型相同,且突变酶对DFMO的敏感性与野生型相似。突变体细胞中鸟氨酸的脱羧速率和膜电位均未改变。在该突变体中唯一观察到的变化是其对DFMO的摄取显著减少,细胞内达到饱和水平18微摩尔;该浓度比DFMO对布氏锥虫鸟氨酸脱羧酶的抑制常数(Ki值,130微摩尔)低七倍。显然,突变菌株中DFMO摄取失败是耐药性产生的基础。这些结果还引发了关于布氏锥虫摄取DFMO是通过被动扩散还是转运蛋白介导的问题。DFMO不与鸟氨酸、精氨酸或腐胺的摄取竞争,反之亦然。然而,在DFMO条件下培养几代的突变菌株对鸟氨酸的摄取有极大增强,对腐胺的摄取有适度提高。在无DFMO的情况下对突变菌株进一步传代时,两者均降至正常水平。

相似文献

1
A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.一株对α-二氟甲基鸟氨酸具有抗性的布氏锥虫突变体。
Mol Biochem Parasitol. 1987 Jan 2;22(1):9-17. doi: 10.1016/0166-6851(87)90064-8.
2
Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.与布氏锥虫摄取α-二氟甲基鸟氨酸及耐药性相关的生化变化
Mol Biochem Parasitol. 1987 Oct;25(3):227-38. doi: 10.1016/0166-6851(87)90086-7.
3
Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.布氏布氏锥虫:鸟氨酸脱羧酶缺失的血流形式突变体的特征及α-二氟甲基鸟氨酸的作用
Exp Parasitol. 1998 Mar;88(3):255-7. doi: 10.1006/expr.1998.4237.
4
Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.杜氏利什曼原虫对α-二氟甲基鸟氨酸的抗性与鸟氨酸脱羧酶活性增加有关。
Mol Biochem Parasitol. 1990 Feb;39(1):77-89. doi: 10.1016/0166-6851(90)90010-j.
5
Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.DL-α-二氟甲基鸟氨酸对敏感及耐药布氏布氏锥虫的评估
Acta Trop. 1991 Jan;48(3):223-32. doi: 10.1016/0001-706x(91)90050-t.
6
Polyamine depletion following exposure to DL-alpha-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei.在体内和体外暴露于DL-α-二氟甲基鸟氨酸后,多胺耗竭会引发布氏布氏锥虫单形株的形态改变和线粒体激活。
J Protozool. 1986 May;33(2):238-43. doi: 10.1111/j.1550-7408.1986.tb05599.x.
7
Effect of putrescine on the respiration of Trypanosoma brucei brucei.腐胺对布氏布氏锥虫呼吸的影响。
Mol Biochem Parasitol. 1986 Aug;20(2):165-71. doi: 10.1016/0166-6851(86)90028-9.
8
Further studies on difluoromethylornithine in African trypanosomes.关于二氟甲基鸟氨酸在非洲锥虫中的进一步研究。
Med Biol. 1981 Dec;59(5-6):434-40.
9
Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine.布氏罗得西亚锥虫临床分离株对DL-α-二氟甲基鸟氨酸的抗性。S-腺苷甲硫氨酸的作用。
Biochem Pharmacol. 1993 Aug 3;46(3):471-81. doi: 10.1016/0006-2952(93)90524-z.
10
Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.鸟氨酸脱羧酶特性的改变导致布氏罗得西亚锥虫对D,L-α-二氟甲基鸟氨酸产生耐受性。
Antimicrob Agents Chemother. 1997 Sep;41(9):1922-5. doi: 10.1128/AAC.41.9.1922.

引用本文的文献

1
Identification of transport systems involved in eflornithine delivery across the blood-brain barrier.参与依氟鸟氨酸通过血脑屏障转运的转运系统的鉴定。
Front Drug Deliv. 2023 May 23;3:1113493. doi: 10.3389/fddev.2023.1113493.
2
Polyamine Metabolism in Parasites: A Promising Therapeutic Target.寄生虫中的多胺代谢:有前途的治疗靶点。
Med Sci (Basel). 2022 Apr 22;10(2):24. doi: 10.3390/medsci10020024.
3
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.昏睡病的药物:其作用机制、耐药性及简史
Trop Med Infect Dis. 2020 Jan 19;5(1):14. doi: 10.3390/tropicalmed5010014.
4
Polyamines in protozoan pathogens.原虫病原体中的多胺。
J Biol Chem. 2018 Nov 30;293(48):18746-18756. doi: 10.1074/jbc.TM118.003342. Epub 2018 Oct 17.
5
Genetic dissection of drug resistance in trypanosomes.寄生虫抗药性的遗传学剖析。
Parasitology. 2013 Oct;140(12):1478-91. doi: 10.1017/S003118201300022X. Epub 2013 Apr 3.
6
A molecular mechanism for eflornithine resistance in African trypanosomes.非洲锥虫依氟鸟氨酸耐药的分子机制。
PLoS Pathog. 2010 Nov 24;6(11):e1001204. doi: 10.1371/journal.ppat.1001204.
7
Chemotherapy of human african trypanosomiasis.人类非洲锥虫病的化疗
Interdiscip Perspect Infect Dis. 2009;2009:195040. doi: 10.1155/2009/195040. Epub 2009 Aug 20.
8
Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods.运用化学和遗传方法剖析布氏锥虫双功能硫醇嘌呤合酶-酰胺酶的必需性。
Mol Microbiol. 2009 Nov;74(3):529-40. doi: 10.1111/j.1365-2958.2009.06761.x. Epub 2009 Jun 24.
9
African sleeping sickness.非洲昏睡病
BMJ. 2008 Mar 29;336(7646):679-80. doi: 10.1136/bmj.39505.490544.BE. Epub 2008 Mar 5.
10
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.人类非洲锥虫病:与一种被忽视疾病的药理学再接触。
Br J Pharmacol. 2007 Dec;152(8):1155-71. doi: 10.1038/sj.bjp.0707354. Epub 2007 Jul 9.